MedVoice AI ™ will collaborate with Mayo Clinic to develop AI-powered technology that optimizes the management of respiratory disorders.
From: MedVoice AI, Inc.
PITTSBURGH, – December 4, 2024, – PRLog — MedVoice AI, Inc., the leader in conversational AI powered healthcare, has entered a know-how deal with Mayo Clinic. The agreement will allow MedVoice AI to develop innovative AI programs for patients managing cardiopulmonary disorders at home, including COPD, conges This AI-powered innovation will be the first of its kind for at-home care, utilizing an exclusive right to
MedVoice will collect information about a patient’s medical history, health status, and comorbidities. It is a goal to use real-time data from medical devices to guide patients through their home treatment. Patients could learn more about their home technology by asking detailed questions and receiving answers in real-time. This conversational and empathetic troubleshooting can reduce stress and provide vital assistance to safely manage serious health conditions at home. MedVoice technology aims to start a conversation instead of blaring an alarm.
As an example, “Your pulse ox reading is lower than normal—is your oxygen nearby?” the patient could respond with questions: “How much lower is this reading than normal?” the goal is for MedVoice powered devices to provide real-time responses. “Your previous normal readings were 94 to 95. This reading is 89. Are you feeling short of breath?”
Through this collaboration, Mayo Clinic hopes to leverage its clinical expertise in order to define best practices which have the greatest impact cardiopulmonary care outcomes.
Focus groups with Mayo Clinic patients and practitioners will help MedVoice make sure that every interaction is empathetic and helpful, intuitive and extremely user-friendly. MedVoice’s patented conversational AI will incorporate these solutions to provide enhanced personalized care.
Hospitals, clinicians and patients are under increasing pressure. This makes the need for home healthcare services critical. At-home care is often overwhelming for patients. This can lead to life-threatening situations and complications without the proper training and support. To truly support patients through complex chronic care, at-home services and technologies must be effective and safe.
MedVoice aims to deliver a scalable, affordable solution that will relieve the burden of clinicians and hospital systems and provide 24/7 effective support to patients.
“Health literacy, access to care, and effective self-management are critical challenges facing healthcare today,” Dr. Robert Gillio, the co-founder of MedVoice AI, says, “Our collaboration with Mayo Clinic represents a significant step forward in addressing these challenges by creating a smart medical device ecosystem designed to provide comprehensive, personalized guidance to individuals in real-time.”
about MedVoice AI, Inc.,
MedVoice AI, Inc., is a pioneering technology company that focuses on revolutionizing healthcare with AI-driven smart devices. Its unique technology combines artificial intelligence with personalized, conversational healthcare–simplifying the management of serious chronic health conditions for patients and their providers. Please note that Mayo Clinic holds a financial interest
in the technology mentioned in this press release. Mayo Clinic will use any revenue it receives to support its non-profit mission of patient care, research, and education.
http://www.medvoice.ai
[END]